Objectives: To investigate the clinical relevance and molecular epidemiology of extended-spectrum b-lactamase (ESBL)-producing Klebsiella species in animals.
Introduction
Extended-spectrum b-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae pose a serious threat to public health as they frequently cause severe infections, commonly leaving only limited therapeutic options. 1 Also, in the veterinary field there is growing concern over the frequency of ESBL-producing bacteria, as these microorganisms pose a dual risk as infectious agents for animals and as putative zoonotic pathogens.
2 So far, researchers preferentially put efforts into unravelling ESBLs produced by E. coli, whereas fewer data exist about the occurrence of multidrug-resistant Klebsiella spp., particularly in animals. 3 -6 ESBL-producing strains have been isolated from bovine mastitis and a variety of clinical conditions in horses, dogs, cats, swine and broilers. 7 -11 In contrast to the medical field, where epidemic clones such as K. pneumoniae ST15-CTX-M-15 and other frequently appearing phylogenetic lineages have been identified, 1,12 -14 the population biology of Klebsiella spp. from animal sources has been addressed only scarcely. 9 -11,15 -17 Here, we report on the frequency, genotypic and phylogenetic characteristics of ESBLproducing K. pneumoniae from veterinary clinical samples. and testing for presumptive ESBL production was performed using Vitek w 2 (bioMé rieux, Germany; AST-GN38 and AST-N062). ESBL production was verified by a double-disc confirmation test and the isolates were further screened for AmpC production by agar disc diffusion testing with cefoxitin discs and by PCR to detect acquired AmpC genes. 18, 19 ESBL producers were screened for bla TEM-type , bla SHV-type , bla CTX-M-type and bla OXA-type genes and for non-b-lactam resistance and integrase genes by PCR and sequencing. 20 In case no common ESBL gene was identified, strains were tested for the bla PER , bla GES and bla VEB gene families (Table S1 , available as Supplementary data at JAC Online). Sequences were analysed using Lasergene 6 (DNAStar, Germany) and Ridom SeqSphere 0.9.19 (http:// www3.ridom.de/seqsphere). Thirteen human ESBL-producing K. pneumoniae from Germany and Denmark were included for comparative purposes.
Materials and methods

3,13
Conjugation experiments
Transfer of b-lactam resistance was achieved by the filter mating method using recipient E. coli K12-J53 (Azi R ). Plasmid replicons were determined with a PCR-based typing kit (DIATHEVA, Italy).
PFGE
Macrorestriction analysis was performed as described previously. 21 Profiles were compared using BioNumerics (Version 6.6, Applied Maths, Belgium) and cluster analysis of Dice similarity indices based on UPGMA.
Multilocus sequence typing (MLST)
MLST was performed according to a published protocol. 22 Allele sequences (LGC Genomics, Berlin, Germany) were analysed with Ridom SeqSphere in line with a database available online (www.pasteur.fr/mlst). eBURST V2 analysis (http://eburst.mlst.net/9.asp) was performed to identify clonal complexes (CCs), defined as groups of two or more independent isolates sharing identical alleles at six or more loci.
Results
Klebsiella species distribution and ESBL rate according to host and clinical history Of 1519 strains, 68.2% were K. pneumoniae subsp. pneumoniae, 25.4% Klebsiella oxytoca, 5.0% K. pneumoniae subsp. ozaenae and 1.4% other or undefined Klebsiella (Raoultella) species. Eighty-nine (5.9%) strains, predominantly K. pneumoniae subsp. pneumoniae, were confirmed as ESBL producers (Table 1) . They were from seven European countries, including Germany (n¼ 72; 30 clinics in 27 towns), Italy (n¼ 10), France, Luxembourg (n¼ 2 each), Spain, Denmark and The Netherlands (n ¼ 1 each) and were recovered from dogs (n ¼ 50), cats (n ¼ 27), horses (n ¼ 5) and other animals (n ¼ 7). ESBL producers were most frequent among skin/soft tissue infections (20.1%), followed by infections of the bladder/kidneys (13%) and eyes/ears (10%).
Genotypic and phenotypic resistance
ESBL-producing Klebsiella spp. predominantly harboured bla CTX-M-15 (85.4%) and less frequently bla CTX-M-1 (5.6%), bla CTX-M-3 , bla CTX-M-9 , bla SHV-2 and bla SHV-12 (1.1% each) ( Figure S1 , available as Supplementary data at JAC Online). Neither phenotypic cefoxitin resistance nor acquired AmpC 
Clonal analysis and phylogenetic relatedness of ESBL-Klebsiella
Animal and human strains grouped into seven PFGE clusters (A-G) and 19 singletons ( Figure S1 ). The largest cluster G contains 43 CTX-M-15-SHV-28 K. pneumoniae exclusively from animal sources from 15 German clinics. In four of these clinics, the clone has been isolated from 3 -10 different animals at different sampling times ( Figure S1 ). Within cluster C (n ¼ 29), strains from animals show high similarity to human strains.
We found nine STs among 62 K. pneumoniae, with ST15 being the predominant one (85.5%). All strains typed within the major clusters C and G belonged to ST15. Further STs were ST70 (n ¼ 2), ST101, ST188 and five novel STs (ST988 -ST992) (n ¼ 1 each). To put our MLST data into a global context, an in silico dataset was established that contained 2331 K. pneumoniae from human and animal sources ( Figure 1 ) and included 940 STs separated into 30 CCs and 471 singletons. We further defined clonal groups (CGs) of CC37, as this CC tended to merge, constituting a group of unrelated STs rather than one diversified from a single common ancestor.
14 More than 90% of ST15 strains expressed Figure 1 . eBurst analysis of allelic profiles of 2331 K. pneumoniae strains (phenotypic ESBL, 28%; carbapenemase production, 11%; and unknown resistance phenotype, 61%) from the MLST database (www.pasteur.fr/mlst) [n ¼1580; isolates from animal (98), human (1427), environmental (30) and unknown (25) sources], previously published but not listed in the MLST database [n ¼ 682; isolates from animals (17) and humans (665)] (see Supplementary data, references for Figure 1 ) and finally from this study [isolates from animal (62) and human (7) Ewers et al.
CTX-M-15, which is currently the most common ESBL type in human Klebsiella spp. as well (.70% of human ESBL strains of the in silico dataset), abundantly occurring in ST15 strains ( Figure S2 , available as Supplementary data at JAC Online).
Discussion
This study shows that ESBL-producing K. pneumoniae are far from being a rare finding in veterinary clinical samples. Within the given study period, third-generation cephalosporin-resistant (3GCR) K. pneumoniae accounted for 12% of invasive isolates from humans in European countries. 23 Supposed that almost twothirds of 3GCR K. pneumoniae isolates represent ESBL producers, as recently stated by the European Centre for Disease Prevention and Control (ECDC), these 12% only marginally exceed the overall percentage of 8% of ESBL producers identified among our animal strains. The primary sites of isolation almost resembled the situation in the medical field, where high numbers of ESBL-positive Klebsiella spp. are likewise isolated from urine and wounds.
14 CTX-M-15, the dominating b-lactamase type in the present study, is also considered the most common ESBL in K. pneumoniae from patients worldwide, indicating its global distribution across species. 12 -14,24 -26 This supports previous findings about the generally higher abundance of CTX-M-15 in companion animal isolates, whereas CTX-M-1 is more commonly reported for livestock.
2 Although CTX-M-15 was the predominant ESBL type in our isolates, they carried bla CTX-M-15 on different plasmids, suggesting frequent horizontal transfer. Among the replicon types identified were IncFII, IncFIA and IncFIB, all of which are considered main vehicles of bla CTX-M-15 dissemination in humans. 27 Recently, bla CTX-M-15 was found to be located on a novel plasmid scaffold widely distributed in K. pneumoniae from animals. The authors suggested that companion animals may be reservoirs for CTX-M-15-producing K. pneumoniae evolving separately from the human source of CTX-M-15 producers. 10 We found strong indications for nosocomial events in 5 of 45 veterinary clinics. This is in line with recent findings of clinically associated infections with OXA-48-ST15 K. pneumoniae in dogs in Germany 15 and the spread of CTX-M-15-ST274 K. pneumoniae in a veterinary clinic in France. 10 Another study reported about recurrent clinically acquired urinary tract infections in pets with ST15-CTX-M-15 K. pneumoniae, mirroring the situation observed for nosocomial infections in human hospitals. 9 However, the predominance of one CG, namely CG15 (85.5%), among our ESBL producers may be not simply attributable to nosocomial dissemination, since 28 clinics were represented by one ST15-CTX-M-15 strain only. One case of pneumonia in a dog in Italy due to CTX-M-15-ST15 K. pneumoniae further hints to the emergence of this clone in other countries. 11 Diancourt et al. 22 identified 40 STs among 67 predominantly human K. pneumoniae, hinting towards a high genetic diversity of this species. Weak clonality was also observed among 3GCR K. pneumoniae from major health institutions in Africa and Vietnam.
14 However, CG15 (17%) was among the two major CGs identified, circulating in almost all participating centres but predominantly expressing CTX-M-1.
14 Nevertheless, the spread of ESBL-producing K. pneumoniae is basically multiclonal, as .130 STs have been published as ESBL producers so far.
Generally, CG15, CG23 and CG258 appear predominant among the entire K. pneumoniae population (Figure 1 ). CG15 is a wellknown 'ESBL clonal group', whereas CG258 is particularly linked with the global dissemination of KPC-2 producers while ESBLs, including CTX-M-15, have been reported as well. 1, 12, 13 In CG23, ESBL producers have been described only sporadically.
14 Our data support the observation of the worldwide expansion of CG15 strains as we identified them among both epidemiologically related and unrelated animals. Less frequently observed STs among our isolates, e.g. ST101-CTX-M-15 and ST70-CTX-M-15 K. pneumoniae, were previously recovered from human patients as well and might also be of zoonotic relevance. 24 -26 ST101-CTX-M-15 strains even accounted for the first OXA-48 outbreak in Spain. 28 Very recently, ST101-CTX-M-15 strains have also been reported as a major type among clinical cases in dogs and cats in Italy. 11 In conclusion, the frequent occurrence and nosocomial dissemination of multidrug-resistant CTX-M-15-producing K. pneumoniae determines animals as a relevant source of such strains. Whether they form a uniform pool with human isolates or represent a separate group of strains undergoing a parallel evolution remains unknown. Although there is no evidence for a direct transfer of multidrug-resistant K. pneumoniae between animals and humans, further studies should unravel relevant transmission paths of these life-threatening bacteria across both populations.
